HOME >> BIOLOGY >> NEWS
Pain killer fights breast cancer by targeting key enzyme

A painkilling medication appears to halt the production of an enzyme that is key to a common form of breast cancer, a new study using tissue cultures suggests.

The drug is called nimesulide. In laboratory experiments on breast cancer cells, scientists found that derivatives of nimesulide stopped the production of aromatase, the enzyme implicated in estrogen-dependent breast cancer. This form of breast cancer is the most common kind of breast cancer in postmenopausal women.

Aromatase converts hormones called androgens into estrogens, such as the hormone estradiol. Estrogen is a powerful mitogen an agent that causes cells to divide, and too much estrogen can cause cells to divide too quickly.

While many women with estrogen-dependent breast cancer take aromatase inhibitors to control their disease, the problem is that the current inhibitor drugs halt estrogen production throughout the body, said Robert Brueggemeier, a study co-author and a professor of medicinal chemistry and pharmacognosy and dean of the College of Pharmacy at Ohio State University.

"That means that other tissues, like bone and brain, which rely on normal aromatase production, may suffer," he said. "For one, we think that aromatase helps to maintain bone tissue throughout the postmenopausal period. Current aromatase inhibitors may disturb normal bone production there is some suggestion that these drugs may increase the risk of fractures."

The study's results suggest that nimesulide may block aromatase production only in breast tissue. Nimesulide is a non-steroidal anti-inflammatory drug (NSAID), a drug that controls pain and inflammation. Studies of other NSAIDs, such as ibuprofen, have suggested that NSAIDs may reduce breast cancer incidence by 40 percent.

However, these drugs tend to halt aromatase production throughout the body.

Brueggemeier presented the work with Bin Su and Serena Landini, both graduate students in Ohio State's pharmacy pr
'"/>

Contact: Robert Brueggemeier
Brueggemeier.1@osu.edu
614-614-292-5711
Ohio State University
29-Mar-2006


Page: 1 2 3

Related biology news :

1. Aphids make chemical weapons to fight off killer ladybirds
2. Revealed -- Mosquito genes that could be controlling the spread of killer viruses
3. Common cancer gene sends death order to tiny killer
4. Bacteria show promise in fending off global amphibian killer
5. Antioxidant found in many foods and red wine is potent and selective killer of leukemia cells
6. Veterinary scientists explore poultry virus as cancer killer
7. Turning a cellular sentinel into a cancer killer
8. Cellular killer also important to memory
9. Painkillers may threaten power of vaccines
10. A new target for painkillers
11. Hope for major advance in fighting world killer disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2019)... ... October 09, 2019 , ... Calcium & Bone Health Institute ... in Vancouver, Canada on September 23-24 for two days. The purpose of symposium ... healthy bone and to prevent calcium-related diseases. The theme of this year was ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... National Research Council of Canada (NRC) to create the Laboratory of Industrial ... and in manufacturing, LIFT will offer a competitive capacity to accelerate the ...
(Date:10/8/2019)... ... October 07, 2019 , ... ... of imaging modalities such as optical projection tomography, optical coherence tomography, echocardiogram, light ... to generate these data sets inhouse, a lot of research groups struggle with ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... 2019 , ... Cheyenne is a beautiful and strong Quarter Horse and a ... Rebel’s Run , which offers riding lessons and trail riding in Afton, Virginia. ... Mimi describes her as her “go to horse.” Thus, you can imagine ...
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... ... September 24, 2019 , ... Personalized ... training and site qualification for clinical trial sites and physician investigators. The ... potential clinical trial participants. , Clinical trial sites are currently located in San ...
(Date:9/17/2019)... , ... September 17, 2019 , ... Tucker, a Labrador ... only four months old, Tucker was limping and lame on his right hip and ... dysplasia and it was called “the worst case the vet had seen.” He was ...
Breaking Biology Technology:
Cached News: